Meridian Bioscience, Inc. Reports Third Quarter And Nine Months Operating Results, Declares Regular Cash Dividend, And Reaffirms Fiscal 2014 Guidance

CINCINNATI--(BUSINESS WIRE)--Meridian Bioscience, Inc. (NASDAQ: VIVO) today:

•reported fiscal 2014 third quarter and first nine months net sales of $47.2 million and $142.1 million, respectively, flat and an increase of 2%, respectively, from the same periods of the prior fiscal year;

•reported third quarter operating income of $13.1 million, a decrease of 16% from the same period of the prior fiscal year;

Help employers find you! Check out all the jobs and post your resume.